USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark LIMERICK BIOPHARMA was filed as Word mark on 04/09/2010 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Word mark |
| File reference | 85010595 |
| Application date | April 9, 2010 |
| Publication date | November 2, 2010 |
Trademark owner
601 Gateway Boulevard
940807031 South San Francisco
US
940807031 South San Francisco
US
Trademark representatives
goods and services
5
pharmaceutical preparations for the treatment of Tangiers disease, nonalcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), cystic fibrosis, human immunodeficiency virus (HIV), diabetes, hyperlipidemia, cancer, atherosclerosis, hypertension, insulin resistance, dyslipidemia, and hepatic cholestasis; pharmaceutical preparations for the treatment of the metabolic system, the central nervous system, the peripheral nervous system, the liver, the immune system, the renal system, and the cardiovascular system; pharmaceutical preparations for the treatment of metabolic diseases and disorders, infectious diseases, autoimmune diseases and disorders, inflammatory disorders, and cardiovascular disease; pharmaceutical preparations for the treatment of renal diseases, disorders and dysfunction; pharmaceutical preparations for the prevention and treatment of organ rejection; pharmaceutical preparations for use in tissue and organ transplantation, for adjuvant use in tissue and organ transplantation, for use in oncology, and for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral related diseases and disorders, and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of pain; pharmaceuticals, namely, anti-infectives, immunosuppressants, anti-inflamatories, and antivirals; analgesic pharmaceutical preparations; anti-diabetic pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
ID: 1385010595